April 1st 2025
Family physician and researcher Mark Ebell, MD, discusses the clinical implications, efficacy, and role of gepotidacin in UTI management.
FDA Advisers Endorse Natalizumab (Tysabri) for Crohn's Disease
August 2nd 2007GAITHERSBURG, Md. -- FDA advisers have recommended approval of the problem-ridden multiple sclerosis drug natalizumab (Tysabri) for treatment of moderate to severe Crohn's disease, but only with extensive safety monitoring.
Cerebral air embolism resulting from an airplane flight
August 1st 2007The authors describe a case of air embolism that developed during a plane flight in a woman who had a congenital cystic adenomatoid malformation. They review the pathophysiological mechanisms, risk factors, clinical features, and treatment of air embolism.
Burn Victim With GI Symptoms and Fever
August 1st 2007For several days, a 50-year-old man has had copious green stools, vomiting, and fever. His symptoms began shortly after he was discharged from a regional burn center, where he was treated for full-thickness burns that covered 60% of his body surface.
Chief Justice Has High Risk for Repeat Seizures, Specialists Say
July 31st 2007ROCKPORT, Me. -- With two seizures in his medical history, the latest yesterday, Supreme Court Chief Justice John G. Roberts, Jr., has a greater than 50% risk for a third, and may require antiepileptic drugs, specialists said today.